300015:SZSEAier Eye Hospital Group Co., Ltd. Class A Analysis
Data as of 2026-09-02 - not real-time
CN¥8.30
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At ¥8.30, Aier Eye Hospital Group Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 6.6% over the past 30 days. Relative strength is 41.3 — neutral — and the MACD signal is bearish. The recent range runs from support at ¥8.15 up to resistance at ¥9.28.
Multiples put this in fair territory: 30.7 times earnings against the sector's 30.6. Analyst price targets sit 57.4% above the current price. The 2.17% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 26.6%, a beta of 0.06 and a maximum drawdown of 39.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Multiples put this in fair territory: 30.7 times earnings against the sector's 30.6. Analyst price targets sit 57.4% above the current price. The 2.17% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 26.6%, a beta of 0.06 and a maximum drawdown of 39.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 9.99
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 30.7 versus sector average of 30.6
- Trading below the 200-day average of 9.99
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 30.7 versus sector average of 30.6
- Analyst targets imply +57.4% versus the current price
- Dividend yield of 2.17%
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin11.17%
P/E Ratio30.7
ROE11.78%
ROA8.54%
Debt/Equity31.39
P/B Ratio3.3
Op. Cash FlowCN¥5.5B
Free Cash FlowCN¥2.6B
Industry P/E30.6
Technical Analysis
TrendBearish
RSI41.3
SupportCN¥8.15
ResistanceCN¥9.28
MA 20CN¥8.57
MA 50CN¥8.59
MA 200CN¥9.99
MACDBearish
VolumeDecreasing
Fear & Greed Index92.09
Valuation
Fair ValueCN¥3.70
Target PriceCN¥13.06
Upside/Downside57.39%
GradeFair
TypeBlend
Dividend Yield2.17%
Risk Assessment
Beta0.06
Volatility26.62%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.